1. Population based diabetes screening is associated with less insulin therapy compared to usual care

   Vos, R. C., den Ouden, H., Daamen, L. A., Bilo, H. J. G., Denig, P. & Rutten, G. E. H., Oct-2018, In : Diabetologia. 61, p. S424 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

2. Prediction models for the risk of diabetic foot in people with type 2 diabetes: a systematic review and external validation study

   Beulens, J. W., Yauw, J. S., Peelen, L. M., Feenstra, T. L., Moons, K. G., Slieker, R. C., Herings, R. M., Elders, P. J., Nijpels, G. & van der Heijden, A. A., Sep-2019, In : Diabetologia. 62, p. S459-S460 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

   Zhou, Z., Jardine, M., Perkovic, V., Matthews, D. R., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Desai, M., Oh, R., Simpson, R., Watts, N. B. & Neal, B., Oct-2019, In : Diabetologia. 62, 10, p. 1854-1867 14 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

   Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A. & Mayer, G., Jul-2019, In : Diabetologia. 62, 7, p. 1154-1166 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Blood Mg2+ is more closely associated with hyperglycaemia than with hypertriacylglycerolaemia: the PREVEND study

   van Dijk, P. R., Schutten, J. C., Jeyarajah, E. J., Kootstra-Ros, J. E., Connelly, M. A., Bakker, S. J. L. & Dullaart, R. P. F., Sep-2019, In : Diabetologia. 62, 9, p. 1732-1734 3 p.

   Research output: Contribution to journal › Letter › Academic › peer-review

View all (201) »